Advertisement

Topics

Red blood cells with superpowers: Rubius rallies a $120M Series B

00:38 EDT 21 Jun 2017 | MedCity News

Red blood cells tend to mind their own business, but what if they could be engineered to replace missing enzymes, activate T-cells, or bind tumor cells? It’s an exciting possibility that has garnered a highly oversubscribed $120 million Series B.

Original Article: Red blood cells with superpowers: Rubius rallies a $120M Series B

NEXT ARTICLE

More From BioPortfolio on "Red blood cells with superpowers: Rubius rallies a $120M Series B"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...